SAM
LEGN icon

Storebrand Asset Management’s Legend Biotech LEGN Stock Holding History

Storebrand Asset Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$972K Buy
33,660
+1,902
+6% +$51.3K ﹤0.01% 653
2026
Q1 		$575K Buy
31,758
+2,177
+7% +$41.5K ﹤0.01% 665
2025
Q4 		$643K Buy
29,581
+1,584
+6% +$45.4K ﹤0.01% 669
2025
Q3 		$913K Buy
27,997
+5,462
+24% +$202K ﹤0.01% 650
2025
Q2 		$800K Hold
22,535
– – ﹤0.01% 656
2025
Q1 		$765K Hold
22,535
– – ﹤0.01% 671
2024
Q4 		$733K Buy
22,535
+3,506
+18% +$145K ﹤0.01% 695
2024
Q3 		$927K Sell
19,029
-505
-3% -$26.9K ﹤0.01% 687
2024
Q2 		$865K Sell
19,534
-11,914
-38% -$550K ﹤0.01% 682
2024
Q1 		$1.76M Buy
31,448
+9,319
+42% +$562K 0.01% 638
2023
Q4 		$1.33M Buy
22,129
+746
+3% +$47.3K ﹤0.01% 668
2023
Q3 		$1.44M Hold
21,383
– – 0.01% 650
2023
Q2 		$1.48M Buy
21,383
+951
+5% +$62.1K 0.01% 654
2023
Q1 		$985K Buy
20,432
+2,451
+14% +$120K 0.01% 679
2022
Q4 		$898K Buy
17,981
+8,682
+93% +$421K 0.01% 681
2022
Q3 		$379K Buy
9,299
+645
+7% +$30.3K ﹤0.01% 726
2022
Q2 		$476K Buy
+8,654
New +$365K ﹤0.01% 725

Other funds holding LEGN

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Storebrand Asset Management's LEGN Position: Q2 2026 in Review

Storebrand Asset Management increased its Legend Biotech (LEGN) stake by 6% in Q2 2026, buying an estimated $51.3K and bringing the position to 33,660 shares worth $972K. The position accounts for ﹤0.01% of the portfolio, ranked #653.

Storebrand Asset Management first reported a position in LEGN in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.76M in Q1 2024. 201 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Storebrand Asset Management held 33,660 shares of Legend Biotech worth $972K as of Q2 2026.
  • Storebrand Asset Management bought 1,902 Legend Biotech shares in Q2 2026, an estimated $51.3K.
  • Legend Biotech made up ﹤0.01% of Storebrand Asset Management's portfolio in Q2 2026, its #653 holding.
  • Storebrand Asset Management first reported a position in Legend Biotech in Q2 2022 and has held it in 17 quarters since.
  • Storebrand Asset Management's Legend Biotech position peaked at $1.76M in Q1 2024.
  • 201 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Storebrand Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.